Bill Sponsor
House Bill 3296
116th Congress(2019-2020)
Affordability is Access Act
Introduced
Introduced
Introduced in House on Jun 14, 2019
Overview
Text
Introduced
Jun 14, 2019
Latest Action
Jun 17, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3296
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Massachusetts
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
Connecticut
Democrat
District of Columbia
Democrat
Illinois
Democrat
Massachusetts
Democrat
Massachusetts
Democrat
Minnesota
Democrat
Nevada
Democrat
Washington
Democrat
Washington
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Affordability is Access Act

This bill establishes several requirements relating to health-insurance coverage of, and access to, over-the-counter contraceptives.

Specifically, the bill requires the Department of Health and Human Services, the Department of Labor, and the Department of the Treasury to specify that private health-insurance plans must cover over-the-counter contraceptives that are approved by the Food and Drug Administration (FDA), even without a prescription. Under current law, private health-insurance plans (with some exceptions) must cover FDA-approved prescription contraceptives, without cost-sharing requirements.

The bill also prohibits retailers from interfering with an individual's access to oral contraceptives that are meant for routine, daily use and are FDA-approved for use without a prescription.

Text (1)
June 14, 2019
Actions (3)
06/17/2019
Referred to the Subcommittee on Health.
06/14/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Labor, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
06/14/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:51:05 PM